Brain Aneurysm Treatment Market - Key Players
Some of key the players in the market are:
• Medtronic Plc.
• Codman & Shurtleff Inc.
• Raumedic AG
• Vittamed
• Sophysa Ltd.
• MicroPort Scientific Corporation
• Orsan Medical Technologies
• Spiegelberg GmbH
• Johnson & Johnson
• Sophysa Ltd
• HaiWeiKang
• Head Sense Medical
• InfraScan Inc.
• Integra Life Sciences Corporation
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4561 .
Brain Aneurysm Treatment Market - Overview
A brain aneurysm is also known as cerebral aneurysm or intracranial aneurysm (IA). It is a weak bulging spot present on the wall of a brain artery. Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it. The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH). This kind of hemorrhage may lead to coma, stroke, and/or death. There are number of factors that contribute to the occurrence of brain aneurysms, such as cigarette smoking, injury or trauma, blood infections, and many others. Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.
A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market. Presence of brain aneurysm in the family history are also fuelling up the market to a great extent. According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%. Despite these drivers, there are some issues associated with brain aneurysm treatment market. High cost of management for aneurysmal subarachnoid hemorrhage, and unknown symptoms of unruptured brain aneurysm may hinder the growth of market to an extent. Brain Aneurysm Foundation states that Brain aneurysms are mostly prevalent at the age of 35 – 60 years whereas aneurysmal hemorrhagic stroke is more common in people aged 50 years.